NR3C2 and myocardial infarction: On hospital admission, patients with prior MI more often had an existing therapy with ACE inhibitors or angiotensin receptor blockers (82.0 vs. 73.6%, p < 0.001), beta-blockers (84.7 vs. 73.6%, p < 0.001), mineralocorticoid receptor blockers (44.9 vs. 34.6%, p < 0.001) or diuretics (75.9 vs. 65.8%, p < 0.001).